Ross M Campbell, MD Dermatology - MOHS-Micrographic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1180 Resurgence Dr, Suite 100, Watkinsville, GA 30677 Phone: 706-543-5858 Fax: 706-543-2050 |
Natalie Marie Meeks, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1180 Resurgence Dr Ste 100, Watkinsville, GA 30677 Phone: 706-543-5858 |
Cedar Helen Malone, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1180 Resurgence Dr Ste 100, Watkinsville, GA 30677 Phone: 706-543-5858 |
Adam Swigost, MD Dermatology Medicare: Medicare Enrolled Practice Location: 1220 Langford Dr Ste 103, Watkinsville, GA 30677 Phone: 706-353-8220 Fax: 404-816-7929 |
Dr. Kristen Ann Thomas, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1180 Resurgence Dr, Suite 100, Watkinsville, GA 30677 Phone: 706-543-5858 Fax: 706-543-2050 |
Dr. Karen R Maffei, M.D. Dermatology - Procedural Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1050 Thomas Ave, Watkinsville, GA 30677 Phone: 706-769-1550 Fax: 706-769-1514 |
News Archive
VOA News examines AIDS among high-risk groups in Burma, also known as Myanmar. "Burma's AIDS epidemic mostly affects marginalized groups, such as the gay community," the news service writes, adding, "About one percent of Burma's population is HIV-positive," but "among high-risk groups, such as men who have sex with men, health workers estimate as many as 11 percent have HIV."
Cystic fibrosis is an inherited disorder caused by genetic mutations that disrupt the normal movement of chloride in and out of cells. Among other health problems, cystic fibrosis compromises the lungs' ability to fight infection and breathe efficiently, making it the most lethal genetic disease in the Caucasian population. Patients have an average lifespan of just 30 to 40 years.
The Emergency Medical Treatment & Labor Act was enacted in 1986 to provide access to emergency medical care and transfer for all patients, regardless of immigration status or ability to pay.
Specialty biopharmaceutical company Santarus, Inc.and biotech company Pharming Group NV today announced the receipt of a "refusal to file" letter from the U.S. Food and Drug Administration for the RHUCIN Biologics License Application submitted by Pharming.
› Verified 5 days ago